Providence Cancer Center in Portland, OR, is one of a growing number of facilities that is working to improve care for patients with oral cancer

Over the past decade, thyroid cancer has become one of the most common cancer diagnoses in the U.S., with 55,000 new cases diagnosed annually. According

Recognizing that the number of people being diagnosed with cancer linked to the human papillomavirus (HPV) is on the rise, the National Cancer Institute (NCI)

HuangshanDental.com is pleased to present the next installment of Leaders in Dentistry, a series of interviews with researchers, practitioners, and opinion leaders who are influencing

High-risk genotypes of human papillomavirus (HPV) can be a contributing factor to oral carcinogenesis, especially in younger individuals without known risk factors such as tobacco

Shutting down a specific pathway in cancer cells appears to improve the ability of common drugs to wipe those cells out, according to new research

A combination of the drugs pazopanib and paclitaxel shows promise in slowing anaplastic thyroid cancer (ATC), according to a new study in Science Translational Medicine

Quest Diagnostics has sold substantially all the assets of its OralDNA Labs salivary diagnostics business to Access Genetics, a clinical laboratory with advanced molecular diagnostics

The rising incidence of cancers associated with human papillomavirus (HPV) shows a need to increase HPV vaccination coverage levels, according to a report in the

Oral Cancer Prevention International and CDx Laboratories have combined forces as CDx Diagnostics. The two companies are focused on developing diagnostic systems designed to help